Jefferies Financial Group Research Analysts Lift Earnings Estimates for Agilent Technologies, Inc. (NYSE:A)

Agilent Technologies, Inc. (NYSE:AGet Rating) – Investment analysts at Jefferies Financial Group increased their FY2022 earnings per share (EPS) estimates for shares of Agilent Technologies in a note issued to investors on Wednesday, August 17th. Jefferies Financial Group analyst B. Couillard now expects that the medical research company will earn $5.08 per share for the year, up from their prior forecast of $4.90. The consensus estimate for Agilent Technologies’ current full-year earnings is $4.88 per share. Jefferies Financial Group also issued estimates for Agilent Technologies’ Q1 2023 earnings at $1.37 EPS, Q2 2023 earnings at $1.31 EPS, Q3 2023 earnings at $1.41 EPS and FY2023 earnings at $5.55 EPS.

Agilent Technologies (NYSE:AGet Rating) last released its earnings results on Tuesday, August 16th. The medical research company reported $1.34 earnings per share for the quarter, topping analysts’ consensus estimates of $1.20 by $0.14. The firm had revenue of $1.72 billion during the quarter, compared to the consensus estimate of $1.64 billion. Agilent Technologies had a return on equity of 28.29% and a net margin of 19.94%. The firm’s revenue for the quarter was up 8.3% compared to the same quarter last year. During the same period in the prior year, the firm posted $1.10 earnings per share.

A number of other equities research analysts also recently commented on A. Citigroup increased their price objective on Agilent Technologies from $140.00 to $145.00 and gave the company a “neutral” rating in a research report on Wednesday. Bank of America increased their price objective on Agilent Technologies from $148.00 to $155.00 and gave the company a “buy” rating in a research report on Wednesday. UBS Group assumed coverage on Agilent Technologies in a research report on Wednesday, July 20th. They set a “buy” rating and a $139.00 price objective for the company. Wells Fargo & Company increased their price objective on Agilent Technologies from $130.00 to $135.00 and gave the company an “equal weight” rating in a research report on Wednesday. Finally, The Goldman Sachs Group cut their price objective on Agilent Technologies from $170.00 to $140.00 and set a “buy” rating for the company in a research report on Thursday, July 14th. Four analysts have rated the stock with a hold rating, nine have given a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $153.08.

Agilent Technologies Stock Performance

A opened at $142.29 on Thursday. The company has a market capitalization of $42.50 billion, a price-to-earnings ratio of 32.41, a price-to-earnings-growth ratio of 2.72 and a beta of 1.06. The company has a debt-to-equity ratio of 0.53, a current ratio of 2.01 and a quick ratio of 1.49. Agilent Technologies has a 1-year low of $112.52 and a 1-year high of $179.57. The business has a 50 day moving average price of $123.62 and a two-hundred day moving average price of $127.68.

Insider Transactions at Agilent Technologies

In other Agilent Technologies news, VP Padraig Mcdonnell sold 1,000 shares of the stock in a transaction on Thursday, June 30th. The shares were sold at an average price of $118.62, for a total transaction of $118,620.00. Following the transaction, the vice president now directly owns 17,826 shares of the company’s stock, valued at $2,114,520.12. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. In other news, VP Jacob Thaysen sold 5,879 shares of the firm’s stock in a transaction dated Thursday, June 2nd. The stock was sold at an average price of $127.43, for a total value of $749,160.97. Following the sale, the vice president now directly owns 88,737 shares of the company’s stock, valued at $11,307,755.91. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, VP Padraig Mcdonnell sold 1,000 shares of the firm’s stock in a transaction dated Thursday, June 30th. The shares were sold at an average price of $118.62, for a total value of $118,620.00. Following the completion of the sale, the vice president now directly owns 17,826 shares in the company, valued at $2,114,520.12. The disclosure for this sale can be found here.

Institutional Investors Weigh In On Agilent Technologies

Hedge funds and other institutional investors have recently made changes to their positions in the business. Qube Research & Technologies Ltd lifted its stake in shares of Agilent Technologies by 22.4% in the fourth quarter. Qube Research & Technologies Ltd now owns 236,409 shares of the medical research company’s stock valued at $37,743,000 after buying an additional 43,209 shares during the period. Northwestern Mutual Wealth Management Co. lifted its stake in shares of Agilent Technologies by 86.7% in the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 1,167 shares of the medical research company’s stock valued at $187,000 after buying an additional 542 shares during the period. Advisor Group Holdings Inc. lifted its stake in shares of Agilent Technologies by 4.8% in the fourth quarter. Advisor Group Holdings Inc. now owns 68,195 shares of the medical research company’s stock valued at $10,881,000 after buying an additional 3,140 shares during the period. Mercer Global Advisors Inc. ADV lifted its stake in shares of Agilent Technologies by 17.2% in the fourth quarter. Mercer Global Advisors Inc. ADV now owns 11,528 shares of the medical research company’s stock valued at $1,841,000 after buying an additional 1,690 shares during the period. Finally, Envestnet Asset Management Inc. lifted its stake in shares of Agilent Technologies by 4.5% in the fourth quarter. Envestnet Asset Management Inc. now owns 471,707 shares of the medical research company’s stock valued at $75,308,000 after buying an additional 20,408 shares during the period.

About Agilent Technologies

(Get Rating)

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps, and measurement technologies.

See Also

Earnings History and Estimates for Agilent Technologies (NYSE:A)

Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.